跳至主要内容
临床试验/NCT04746833
NCT04746833已完成不适用

Development and Pilot Testing of LIMIT: a Multicomponent Tool to Support Opioid Tapering

VA Office of Research and Development8 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2021年3月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
8
主要终点
Daily Morphine Milligram Equivalents (MME)

研究概览

简要总结

There are nearly one million veterans being treated with long-term opioid therapy (LTOT) for chronic pain. Numerous short and long-term harms associated with LTOT and mounting evidence suggest they have modest or no benefit. Yet, currently available resources to support veterans to taper are inadequate. Primary care, where most LTOT in VHA is prescribed, is overburdened and straining to meet the challenge of caring for patients with chronic pain. A scalable, relatively inexpensive tapering intervention to support primary care and/or to extend the reach of resource-intensive specialty clinics would be of great benefit to veterans who are not deriving sufficient benefit from LTOT. As such, the goal of this study is to develop and test an interactive, theory-informed, multi-component mobile website to enable veterans to safely taper opioids while managing their pain.

详细描述

The investigators will conduct a 9-month, randomized, two-arm, parallel, open-label, feasibility trial of the multicomponent mobile website called SUMMIT. Eligible participants will be randomized to SUMMIT versus a pain monitoring app. Outcome measures will be collected over 9 months.

To ensure rigor and successful future implementation, the investigators will: 1) develop an evidence based program with features proven to maximize engagement and retention; 2) ensure that the program includes mechanisms to address the diverse obstacles veterans report when consider opioid tapering (e.g. fear of pain flares and abandonment by the system); 3) employ a User Centered Design - with meaningful input from veterans and primary care providers throughout the development and testing phases; and 4) adhere to recently published guidelines for mobile health interventions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Inclusion criteria for Veterans will be primary care patients who are dispensed 84 consecutive days of a stable dose of opioids (reflecting three consecutive 28-day prescriptions) through primary care and who report stable levels of pain intensity over the past month.

排除标准

  • •Exclusion criteria will be Veterans on liquid methadone or buprenorphine for opioid use disorder (OUD) and those who have transitioned to buprenorphine (transdermal or sublingual) for chronic pain, have hearing or visual impairments (not corrected with hearing aids or glasses), psychiatric conditions, cognitive impairments, or participating in a concurrent pain or opioid-related research study.

研究组 & 干预措施

SUMMIT

Experimental

Participants randomized to the experimental intervention will participate in a Motivational Interviewing (MI) session lasting between 30 and 60 minutes with study psychologist. All MI sessions will be audiotaped using a VA-approved digital recorder and transcribed verbatim. Participants will subsequently be shown how to access SUMMIT via a set of unique anonymized login credentials and to navigate the components of SUMMIT on one or more devices, depending on their preference. They will then be trained on how to complete the outcome surveys.

干预措施: SUMMIT (Behavioral)

control

Placebo Comparator

Participants randomized to the control intervention will use an eHealth comparator: My Pain Diary: Chronic Pain Management (iPhone, Android). This app includes a pain monitoring functioning only, and thus will only minimally overlap, if at all, with SUMMIT's components. Control participants will not participate in a MI session. Participants will download the app and be shown how to use the My Pain Diary app and trained how to complete the outcome surveys

干预措施: control (Behavioral)

结局指标

主要结局

Daily Morphine Milligram Equivalents (MME)

时间窗: 9-months

Morphine milligram equivalents per day based on participant self report.

Minutes of Summit App Use

时间窗: 6 months

Total number of minutes of use of the Summit app over the 6 month intervention

Daily Morphine Milligram Equivalents (MME)

时间窗: 9-months

Morphine milligram equivalents per day based on participant self report.

Minutes of Summit App Use

时间窗: 6 months

Total number of minutes of use of the Summit app over the 6 month intervention

次要结局

  • Behavior Intervention Rating Scale (BIRS)(six months)
  • Behavior Intervention Rating Scale (BIRS)(six months)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

Development/Testing of SUMMIT: a Tool to Help... | 临床试验